Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2023 07:00 ET | Source: Oncotelic Therapeutics, Inc.

ONCOTELIC PROVIDES YE 2022 FINANCIAL RESULTS COMPARED TO YE 2021 PRODUCT DEVELOPMENT INITIATIVES AND CORPORATE UPDATE

AGOURA HILLS, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) is providing a summary of its financial results for the year...
February 09, 2023 01:00 ET | Source: Wereldhave N.V.

Wereldhave Full-year results 2022

Total result increased to +€ 76m vs. a loss of € 213m in 2021Direct result 2022 at € 1.63 per share, well within guidance range of € 1.60-1.65Proposed dividend for 2022 at € 1.16 per share...